Hospital-acquired antibiotic-resistant organisms among patients with COVID-19

Background: We sought to use existing in-patient surveillance data to investigate the risk of hospital-acquired antimicrobial-resistant organisms (ARO) among patients with COVID-19 infection.Methods: Prospective case capture was done for patients admitted with COVID-19, as well as those admitted wit...

Full description

Saved in:
Bibliographic Details
Published inCanadian journal of infection control Vol. 37; no. 2
Main Authors Versluys, Kristen A, Pfister, Ted R, Ellison, Jennifer JR, Bush, Kathryn R
Format Magazine Article
LanguageEnglish
Published Winnipeg Infection Prevention and Control Canada 01.07.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: We sought to use existing in-patient surveillance data to investigate the risk of hospital-acquired antimicrobial-resistant organisms (ARO) among patients with COVID-19 infection.Methods: Prospective case capture was done for patients admitted with COVID-19, as well as those admitted with ARO and Clostridioides difficile infections (CDI). Odds ratios (OR) were used to measure the strength of association between COVID-19 infection and the risk of acquiring hospital-acquired ARO and CDI.Results: The odds of acquiring ARO/CDI were statistically higher among patients with hospital-acquired and community-acquired COVID-19 infections (OR=2.68 and 1.79 respectively) compared to persons without COVID-19 (OR=0.53).Conclusions: Our results show an association between COVID-19 infection and the acquisition of ARO/CDI in the in-patient setting. This finding suggests that prolonged hospitalization may expose patients to hospital-acquired infections, and this may have relevance in the management of patients requiring hospitalization for extended periods of time.
ISSN:1183-5702